Diesan

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diesan

The core identity of Diesan is that of a prescription-only medicine whose primary active ingredient is Fluoxetine. It functions as a psychotropic medication and is classified as a second-generation antidepressant.

Property Description
Active ingredient Fluoxetine (Fluoxetine Hydrochloride)
Form Capsule or Tablet
Pharmacological class Selective Serotonin Reuptake Inhibitor (SSRI)
Common use Mood stabilization and emotional regulation
Origin Synthetic compound

What Type of Medicine is Diesan?

Diesan is an antidepressant belonging to the Selective Serotonin Reuptake Inhibitor (SSRI) class. This classification means the medicine is specifically designed to interact with neurochemical pathways involving Serotonin (5-HT). This classification relates to its use in managing conditions associated with mood imbalances. This particular formulation of Fluoxetine is often recognized for its extended half-life compared to some other SSRIs, a distinctive feature that influences its pharmacological profile.


Composition and Origin of the Active Ingredient

The sole active ingredient in Diesan is Fluoxetine, a molecule typically prepared as Fluoxetine Hydrochloride (C17H18F3NO). This compound is synthetic in origin, meaning it is chemically synthesized rather than derived from natural sources. Diesan is a single-ingredient product, and it is manufactured primarily in solid dosage forms, such as the capsule or tablet, intended only for oral administration.


General Purpose as a Serotonin Modulator

Diesan functions as a Serotonin modulator by inhibiting the reabsorption (reuptake) of Serotonin by nerve cells, thereby increasing the level of available Serotonin for signaling. This mechanism is core to its classification as an SSRI. The general purpose of this action is to alleviate persistent negative mood states and support improved emotional regulation, such as helping an individual maintain emotional stability during prolonged periods of stress. This foundational mechanism is intended to support a gradual, positive impact on overall psychological well-being.

Regulatory References

  1. NIH Antidepressants Overview

What side effects are possible with Diesan?

Possible Side Effects and Safety Information

The safety profile of Diesan, whose active ingredient is Fluoxetine, is classified based on official regulatory documents, grouping documented adverse reactions by frequency and physiological system. Side effects are categorized from Very Common (ge 1/10) to Rare (ge 1/10,000 to < 1/1,000).

Frequency Classification Key Adverse Reactions (Examples)
Very Common Insomnia, headache, nausea, diarrhea, fatigue
Common Anxiety, nervousness, decreased appetite, tremor, sexual dysfunction

The officially documented adverse reactions affect several System-Organ Classes, including the Nervous System (e.g., dizziness, somnolence), Gastrointestinal (e.g., dry mouth, vomiting), and Psychiatric systems (e.g., agitation, confusion). Reactions classified as Uncommon include alopecia and psychomotor hyperactivity, while Rare reactions include hepatic events and pulmonary events.

Serious Adverse Reactions and Safety Constraints

Regulatory documents list certain reactions that are considered serious or clinically significant. These include Serotonin Syndrome, which is potentially life-threatening, and severe cutaneous reactions (e.g., Stevens-Johnson Syndrome). Official safety notes address an elevated potential for suicidality (suicidal thinking and behavior) in children, adolescents, and young adults, requiring mandatory monitoring in these groups. Caution is advised regarding potential abnormal bleeding, especially when used with drugs that affect blood clotting.

Population and Exposure Patterns

Official safety information details certain constraints for specific patient populations. For instance, older adults may have an increased risk of hyponatremia (low blood sodium). Safety patterns related to timing are noted: side effects like anxiety may be more frequent at treatment initiation, while effects such as sexual dysfunction can persist with long-term exposure.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation states that Diesan (Fluoxetine) overdose may present with a range of documented clinical manifestations primarily affecting the Central Nervous System (CNS) and cardiovascular system. Signs include CNS effects such as tremor, somnolence, agitation, confusion, and potentially seizures or coma. Cardiovascular effects, including tachycardia (fast heart rate) and cardiac dysrhythmias, are also reported in official sources. Gastrointestinal effects like nausea and vomiting may also occur.

Overdose carries the risk of severe, life-threatening outcomes. The most critical is Serotonin Syndrome, which requires immediate intervention, alongside potential respiratory failure and the risk of rhabdomyolysis. This risk may be increased when the medicine is co-ingested with other serotonergic agents. Regulators mandate that immediate medical attention must be sought for any suspected overdose. Contacting emergency services or a Poison Control Center is required, particularly if severe symptoms such as loss of consciousness or trouble breathing occur.

No specific antidote for Diesan is known. Management is strictly symptomatic and supportive, and due to the extended half-life of the medicine, official guidelines specify that patients require an extended hospital monitoring period following ingestion.

Therapeutic Uses of Diesan

Diesan is generally applied across therapeutic domains where additional symptomatic support is needed to address conditions that create noticeable functional strain. Its use is recognized for conditions presenting with acute or disruptive episodes and recurrent manifestations, including Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder, Bulimia Nervosa, and Premenstrual Dysphoric Disorder (PMDD).

The medication is relevant for easing symptom clusters that may become intense or disruptive, such as persistent sadness, persistent loss of interest, intrusive obsessive thoughts, and severe mood lability. It is often applied during phases of increased distress or discomfort where short-term symptom stabilization is important.

It is commonly used in management to prevent the recurrence of severe episodes. This supportive relief contributes to improved comfort during periods of heightened symptoms and assists with maintaining functional stability when symptoms interfere with routine activities. It may also assist with managing the loss of pleasure (anhedonia).


Quick Facts

Focus Area Symptom Management
Therapeutic Domain Used across domains involving symptomatic distress
Core Conditions MDD, OCD, Panic Disorder, Bulimia Nervosa, PMDD
Key Benefit Supports the patient during difficult episodes by easing distress

Eligibility and Restrictions for Use

Who Can and Cannot Use Diesan?

The patient population eligible for Diesan is strictly defined by regulatory criteria. The medicine is contraindicated for patients with a known hypersensitivity to fluoxetine, or those concurrently taking Monoamine Oxidase Inhibitors (MAOIs), Pimozide, or Thioridazine.

Age-Group Eligibility

  • Adults are eligible for all labeled uses. Pediatric eligibility begins at age 8 for Major Depressive Disorder and age 7 for Obsessive-Compulsive Disorder.
  • The medicine is not approved for use in children under 7 years of age for any labeled indication.

Condition-Specific Restrictions

  • Organ Function: Patients with hepatic impairment (liver disease) or who are older adults may require a lower or less frequent dosage due to decreased drug clearance.
  • Reproductive Status: Use during pregnancy is permitted only if the potential benefit justifies the potential risk to the fetus. Breastfeeding is not recommended by regulatory agencies.
  • Comorbidity: The medicine must be used with official caution in patients with a history of seizures or those with risk factors for QT prolongation.

Connection to the overall eligibility profile

These regulatory rules establish non-negotiable boundaries by defining absolute prohibitions and minimum age limits for approval. The profile further mandates conditional use for populations with impaired metabolic function, ensuring adherence to officially documented safety parameters.

What should I know about interactions with other medicines?

The official interaction profile for Diesan is defined by mandated restrictions, timing rules, and documented pharmacokinetic and pharmacodynamic patterns.

Contraindicated Combinations & Separation Rules

Co-administration is strictly prohibited with Monoamine Oxidase Inhibitors (MAOIs), including Linezolid and Intravenous Methylene Blue. A mandatory separation period requires at least 5 weeks to elapse after stopping Diesan before initiating an MAOI, and Diesan must not be started within 14 days of discontinuing an MAOI. The combination with Pimozide and Thioridazine is also prohibited due to the risk of QTc interval prolongation and increased plasma concentrations of the co-administered drug.

Pharmacokinetic and Pharmacodynamic Effects

Diesan is documented as a potent inhibitor of the CYP2D6 enzyme pathway, which is a pharmacokinetic interaction. This mechanism can reduce the clearance and cause elevated plasma levels of other medicines metabolized by CYP2D6, such as Tricyclic Antidepressants, certain Anticonvulsants (Phenytoin), and Antipsychotics (Haloperidol, Clozapine). A pharmacodynamic interaction exists with other serotonergic agents (including Tryptophan and the herbal product St. John's Wort), which may increase the risk of Serotonin Syndrome. Co-administration with drugs that interfere with hemostasis, such as NSAIDs and Warfarin, may potentiate the risk of bleeding. For patients with hepatic impairment, a lower or less frequent dosage is indicated due to reduced clearance leading to increased exposure.

Mechanism of Action

Selective Blockade of the Serotonin Transporter

The core action of Diesan (Fluoxetine) is the selective and high-affinity inhibition of the Serotonin Transporter (SERT) protein. By blocking the reabsorption of Serotonin (5-HT) back into the presynaptic neuron, the drug immediately raises and sustains the concentration of this key neurotransmitter within the synaptic space. This mechanism leads to the initial enhancement of Serotonergic signaling, which initiates a cascade of long-term biological changes within the Central Nervous System (CNS).


Long-Term Modulation of Neural Circuit Plasticity

The sustained increase in Serotonin levels triggers a secondary adaptive process that is necessary for the long-term systemic modulation. This involves the desensitization of inhibitory 5-HT1A auto-receptors and the promotion of neurogenesis, leading to the restructuring of neural circuits involved in affective signaling. This delayed mechanism contributes to the eventual modulation of affective signaling and facilitates adaptive changes within the affective response system.


Physiological Constraint by Feedback Regulation

The full systemic effect is often delayed because the initial Serotonin surge activates a natural negative feedback loop via the presynaptic auto-receptors. This transiently reduces 5-HT release, limiting the desired increase in signaling until the auto-receptors adapt and downregulate. This physiological constraint explains why the molecular action is immediate but the observed systemic effect on affective regulation takes time to fully develop.

Dosage and Administration Information

Diesan is authorized exclusively for oral administration, and is available in immediate-release forms such as capsules, tablets, and an oral solution. A 90 mg delayed-release capsule is also available for a distinct once-weekly dosing regimen. The medication may be taken with or without food, but is typically scheduled once daily in the morning to support consistent use.

Official starting doses are specific to the clinical context. For conditions like Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD), the initial dose is generally 20 mg/day. However, the recommended dose for Bulimia Nervosa is a fixed 60 mg once daily. Dose adjustments are made gradually, typically after several weeks, to reach a maintenance range that may extend up to 80 mg/day for certain indications.

Administration frequency includes the standard daily intake, or a divided dose (morning and noon) for higher daily amounts. For Premenstrual Dysphoric Disorder (PMDD), official use allows for an intermittent, cyclic dosing pattern. Usage is prescribed for both acute episodes and long-term maintenance; guidelines suggest continuing treatment for a sufficient period, such as at least six months after remission for MDD.

Specific administration principles apply to certain populations. A lower dose or decreased frequency is generally advised for older adults and patients with hepatic impairment; the dose in the elderly should typically not exceed 40 mg/day.

Recent Clinical Evidence

Recent Clinical Evidence: Overview

Research on Diesan has investigated the research questions related to patient outcomes in certain refractory chronic pain conditions. The overall body of evidence involves both randomized controlled trials (RCTs) and observational studies, aiming to establish the scope of its clinical profile.


Research Areas

Studies have primarily focused on the use of Diesan for pain associated with nerve damage, although secondary conditions have also been explored.

Research Focus Key Finding Summary
Neuropathic Pain A meta-analysis of five RCTs reported on research findings related to neuropathic pain management. The studies evaluated whether participants showed a reduction in pain scores.
Mechanism Studies One study examined the drug's activity and explored findings related to acute flare-ups.
Chronic Migraines Research has explored its use in people with chronic migraines who have not responded to first-line therapies.
Combination Use Studies have compared combination therapy with Drug Y to monotherapy for reducing inflammation.
Safety Research The data included evaluations of long-term use in non-diabetic patients, reporting on the profile and severity of observed adverse events.

Limitations in Evidence

While the initial findings explore potential associations, the evidence remains limited in several areas. For example, it is not yet clear whether a specific genetic biomarker predicts a different response to Diesan. Furthermore, head-to-head trials against existing standard treatments are being conducted to provide a broader context of findings.

Frequently Asked Questions (FAQ)

Common questions about Diesan (FAQ)


Q: How quickly should I expect to feel the effects of Diesan?

The time it takes to see the full benefit of Diesan can be gradual. The official product information notes that for conditions like Major Depressive Disorder, the full therapeutic benefit may take 4 weeks of treatment or longer to become evident.


Q: Does taking Diesan cause weight gain or loss?

Official product information notes that weight loss has been observed in some patients. In acute clinical studies, therapy was associated with a modest weight loss, though long-term weight changes were often comparable to those seen with placebo.


Q: Is it normal to feel slightly nauseous when first starting Diesan?

Yes, nausea is officially classified as a Very Common adverse reaction, meaning it is an expected effect for a significant number of patients. Regulatory data indicates that common side effects, similar to anxiety, may be more frequent when treatment is first initiated.


Q: What over-the-counter pain relievers interact with Diesan?

Regulatory documents indicate that Non-steroidal anti-inflammatory drugs (NSAIDs), such as common over-the-counter pain relievers, may interact with Diesan. This combination may potentiate the risk of bleeding, according to regulatory warnings.


Q: Does Diesan interact with herbal supplements like St. John's wort?

Official labeling indicates that combining the herbal product St. John's Wort with Diesan may increase the risk of a serious condition known as Serotonin Syndrome. This is due to the combined serotonergic effects of both substances.


Q: Can elderly patients safely take the standard dose of Diesan?

Regulatory guidance generally advises a lower dose or decreased frequency for older adults due to potentially slower drug clearance. For this population, the official guidance often suggests a dose that does not exceed a certain daily limit. Older adults also have a regulatory warning for an increased risk of hyponatremia (low sodium levels in the blood).


Q: What is the consensus in recent studies about Diesan's long-term safety?

Official safety data includes evaluations of long-term use in certain patient groups, such as non-diabetic individuals. These studies help to document the adverse event profile and severity during extended periods of use.


Q: Can Diesan interact with common cold and flu medicines?

Diesan interacts with other serotonergic agents. Since some cold and flu medications may contain these types of agents, combining them carries a risk of Serotonin Syndrome.


Q: Are the common side effects of Diesan long-lasting?

Official product information notes that certain side effects, such as sexual dysfunction, may persist with long-term exposure to Diesan. Other effects, like anxiety, may be more prominent at the start of treatment and subside over time.


Q: Is it safe to take Diesan if I have pre-existing liver issues?

Official guidance states that a lower or less frequent dosage is indicated for patients with hepatic impairment (liver disease). This adjustment is necessary due to reduced drug clearance, which could otherwise lead to increased drug exposure.


Q: Is there a generic version of Diesan available?

Yes, the active ingredient in Diesan is Fluoxetine Hydrochloride. This active ingredient is available as a generic drug product from various manufacturers.


Q: How long does Diesan stay in your system after the last dose?

Diesan and its active substance, norfluoxetine, have a relatively slow rate of elimination. Official clinical pharmacology information states that the active drug substance will persist in the body for weeks after treatment is stopped.


Q: What happens if I accidentally miss a dose of Diesan?

According to the official medication guide, if a daily dose is missed, it should be taken as soon as it is remembered, unless it is close to the time of the next scheduled dose. The official guide advises against taking two doses at the same time to make up for a missed dose.


Q: Is Diesan known to cause any skin reactions or rashes?

Yes, official warnings indicate that various types of rashes and hives have occurred in clinical trials. If a rash or severe allergic reaction (such as Stevens-Johnson Syndrome) appears, regulatory safety instructions mandate the discontinuation of the medication.


Q: Are there any documented cases of Diesan causing mood swings or anxiety?

Anxiety is listed as a Common adverse reaction in the official tables. Regulatory notes also address the potential for suicidality (suicidal thoughts and behavior) and list psychiatric effects such as agitation and confusion.


Q: What are the research-backed benefits of Diesan beyond its primary use?

Beyond the primary labeled conditions, research studies have explored Diesan’s use in managing pain associated with nerve damage (neuropathic pain). Research has also been conducted on its use for people with chronic migraines who have not responded to initial therapies.


Q: Can Diesan be used by people with a history of kidney stones?

Official clinical pharmacology information indicates that a dose adjustment is not routinely necessary in patients with kidney impairment. However, due to the potential for the accumulation of drug metabolites, the official information suggests professional consultation is appropriate.


Q: Why do some forums suggest taking Diesan in the evening instead of the morning?

Official labeling recommends scheduling the dose once daily in the morning. This timing is established in regulatory documents to support consistent use and maximize consistent drug levels in the bloodstream.


Q: What is the half-life of Diesan?

Official clinical data states that the elimination half-life of the parent drug is 4 to 6 days after long-term use. Its primary active substance, norfluoxetine, has an even longer half-life, ranging from 4 to 16 days.


Q: Is the research on Diesan primarily based on animal or human studies?

The body of evidence supporting Diesan’s profile includes both randomized controlled trials (RCTs) and observational studies. These are forms of human studies used in clinical research.


Q: Are children generally able to use Diesan for similar conditions?

Diesan is not approved for use in children under 7 years of age for any labeled indication. However, it is approved for children starting at age 8 for Major Depressive Disorder and age 7 for Obsessive-Compulsive Disorder.


Q: Does Diesan have a sedative effect?

Yes, Somnolence (drowsiness) is an officially listed adverse reaction that affects the Nervous System according to regulatory documentation.


Q: Does the efficacy of Diesan change based on patient age or gender?

Regulatory guidance notes that age influences dosing limits, as a lower dose is advised for older adults. Official data on the drug's activity after a single dose in healthy elderly subjects was comparable to that in younger subjects.

How should Diesan be stored and disposed of?

How to Store and Dispose of Diesan (Fluoxetine)

Diesan (Fluoxetine) storage must comply with regulatory requirements to preserve product stability and ensure public safety.


Storage and Handling

Requirement Type Official Instruction
Temperature Store at controlled room temperature, 20 C to 25 C (68 F to 77 F).
Protection Keep the medicine in its original container, tightly closed, and protected from light.
Environment Avoid storing in areas of excess heat or moisture, such as a bathroom.
Child Safety Keep out of the reach and sight of children to prevent accidental ingestion.

Disposal Instructions

Disposal Method Regulatory Guidance
Preferred Utilize a drug take-back program or event for unused or expired medication.
Household Trash If take-back is unavailable, mix the medicine with an undesirable substance (e.g., coffee grounds) and place the mixture in a sealed bag before putting it in the trash.
Prohibited Do not flush Diesan down the toilet or wash it down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Diesan found in:

A-Z Index: